1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
HeartBeam said CEO Robert Eno agreed to leave as CEO and board member effective June 30, 2026, as part of a strategic reorganization. Founder and President Branislav Vajdic will become principal executive officer effective July 1, 2026, and the company said it will license its 3D ECG technology to established partners rather than rely only on direct medical device sales. Shareholders face a leadership transition and a change in business model, and the filing gives no financial results for the period.
Robert Eno's departure as CEO, board member and principal executive officer is effective June 30, 2026; he is expected to enter a consulting agreement.
Branislav Vajdic, Ph.D., becomes principal executive officer effective July 1, 2026; Rich Ferrari, Executive Chairman, co-leads the implementation teams.
Mark Strome resigned from the board and all committees effective immediately, as notified on June 18, 2026.
The company will provide more details on its strategy on its Second Quarter 2026 conference call in August.
GitLab said its Chief Legal Officer, Head of Corporate Affairs and Corporate Secretary, Robin Schulman, will resign effective June 30, 2026, and that the decision was not due to any disagreement with the company. At the June 17, 2026 annual meeting, stockholders re-elected Karen Blasing and Godfrey Sullivan as Class II directors, ratified KPMG LLP as auditor for the fiscal year ending January 31, 2027, and approved executive compensation on a non-binding advisory basis.
Robin Schulman resigns as Chief Legal Officer, Head of Corporate Affairs and Corporate Secretary effective June 30, 2026; she notified the company on June 18, 2026.
Karen Blasing received 243,319,905 votes for and 1,622,441 withheld; Godfrey Sullivan received 221,171,373 for and 23,770,973 withheld. Both terms run to the 2029 annual meeting.
KPMG LLP ratification: 271,236,365 for and 4,277,434 against.
Advisory say-on-pay vote: 235,289,523 for and 8,873,423 against, with 779,400 abstaining.
Ingevity appointed Ryan Cotterman as Vice President, Chief Accounting Officer and principal accounting officer on June 22, 2026. He previously served as Senior Director, Corporate Controller at Ralliant Corporation and held controller and audit roles at Cornerstone Building Brands and Advance Auto Parts. The filing describes a routine finance leadership appointment with a disclosed compensation package.
Base salary of $345,000, bonus target of 40% of base salary, and long-term incentive opportunity of 65% of base salary starting in 2027
One-time sign-on cash bonus of $40,000 and restricted stock units with a grant date target value of $150,000, vesting over three years
Cotterman previously spent 14 years at Ernst & Young LLP and is a licensed Certified Public Accountant in North Carolina
RBC Bearings entered into a new amended and restated employment agreement with CEO Michael Hartnett and an amendment to COO Daniel Bergeron's 2024 agreement, both dated June 23, 2026. The filing changes how equity awards are sized, using the average closing stock price over the six months before the 10-K filing, and aligns ROIC definitions with the company's historical practice.
Hartnett's base salary rises 3.0% to $1,591,350 per year, retroactive to June 1, 2026.
Bergeron's base salary rises 3.0% to $713,482, effective June 1, 2026.
Hartnett's new agreement has an initial term ending March 31, 2027, with automatic annual renewals unless either party gives 90 days' notice.
Equity awards for both executives will be sized on the six-month average closing price before the 10-K filing, rather than the award-date closing price.
Freshpet said co-founder and President Scott Morris will retire effective October 20, 2026, and will serve as an advisor for 18 months afterward. Chief Operating Officer Nicola Baty will take on the additional role of President on the Separation Date.
Scott Morris retires effective October 20, 2026, and is paid base salary until then
Morris becomes an advisor for 18 months at bi-weekly gross payments of $38,904
Nicola Baty, COO since September 2024, will also become President on the Separation Date
Unvested RSUs vest at separation; PSUs vest pro rata through December 2026 subject to performance metrics
Molson Coors said Philip Whitehead, President and CEO of its EMEA&APAC business, is temporarily stepping away from his role due to a medical condition. Simon Kerry, Managing Director of the U.K. and Ireland regional business, will serve as interim Managing Director of EMEA&APAC during the leave. The filing gives no return date or financial figures, so the effect on shareholders is not quantified.
Philip Whitehead, President and CEO of EMEA&APAC, is temporarily stepping away due to a medical condition
Simon Kerry, Managing Director of U.K. and Ireland, named interim Managing Director of EMEA&APAC
Announced June 24, 2026; the filing does not state the length of the leave
Bionano Genomics said it has hired Alex Hastie, Ph.D., as Chief Scientific Officer, effective July 20, 2026. Dr. Hastie previously worked at the company for 14 years and helped develop its core optical genome mapping technologies, and he will lead the company's global scientific strategy and research initiatives. The filing gives no financial figures, and the appointment is an executive hire rather than a change in financial results.
Alex Hastie, Ph.D., appointed Chief Scientific Officer, effective July 20, 2026
Dr. Hastie previously spent 14 years at Bionano helping develop its core technologies
He will lead global scientific strategy, innovation roadmap and research initiatives
Announced by interim CEO and chairman Albert A. Luderer, Ph.D. in a June 24, 2026 press release
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.